...
首页> 外文期刊>BMC Gastroenterology >Villous atrophy in the terminal ileum is a specific endoscopic finding correlated with histological evidence and poor prognosis in acute graft-versus-host disease after allo-hematopoietic stem cell transplantation
【24h】

Villous atrophy in the terminal ileum is a specific endoscopic finding correlated with histological evidence and poor prognosis in acute graft-versus-host disease after allo-hematopoietic stem cell transplantation

机译:回肠末端绒毛萎缩是一种特殊的内镜检查结果,与同种异体造血干细胞移植后急性移植物抗宿主病的组织学证据和预后不良相关

获取原文

摘要

Graft-versus-host disease (GVHD) is a common complication of allo-hematopoietic stem cell transplantation (allo-HSCT). Endoscopic biopsy can provide a definitive diagnosis, but the optimal endoscopic approach for diagnosis remains uncertain. This study evaluated whether ileocolonoscopic imaging can predict acute GVHD severity after allo-HSCT. Consecutive patients who underwent allo-HSCT were referred to our institution, and those diagnosed with acute GVHD by pathology were included in this retrospective study. Fifty-one of 261 patients who underwent ileocolonoscopy were suspected to have acute intestinal GVHD. We performed univariate and multivariate conditional logistic regression with stepwise variable selection; villous atrophy in the terminal ileum remained a statistically significant predictor of GVHD severity (odds ratio, 4.69; 95% confidence interval, 1.07–20.60, P?=?0.04). Patients were classified into three groups based on ileal endoscopic findings in the terminal ileum: group S, GVHD with severe villous atrophy; group M, mild atrophy; and group N, no atrophy. Compared with patients in groups M and N, those in group S had significant clinical GVHD at diagnosis (P?=?0.03). In group S, three of four, compared with five of 13 patients in groups M and N, required the addition of second-line agents (P?=?0.02). This study showed that severe atrophy of the terminal ileum predicts severe clinical GVHD that is likely to be refractory to steroid treatment. Thus, the severity of terminal ileum atrophy may serve as a tool in predicting clinically severe GVHD. Trial Registration Number UMIN 000022805 , Registration date July 1, 2016.
机译:移植物抗宿主病(GVHD)是同种造血干细胞移植(allo-HSCT)的常见并发症。内镜活检可以提供明确的诊断,但是用于诊断的最佳内镜方法仍不确定。这项研究评估了异体-HSCT后回肠镜检查是否可以预测急性GVHD严重程度。连续接受异基因造血干细胞移植的患者被转诊到我们的机构,通过病理学诊断为急性GVHD的患者也包括在这项回顾性研究中。在261例接受回肠结肠镜检查的患者中,有51例被怀疑患有急性肠道GVHD。我们通过逐步变量选择进行了单变量和多元条件逻辑回归。回肠末端的绒毛状萎缩仍是GVHD严重程度的统计学显着预测指标(比值比为4.69; 95%置信区间为1.07-20.60,P <= 0.04)。根据回肠末端的回肠内窥镜检查结果,将患者分为三组:S组,严重绒毛萎缩的GVHD组,GVHD组。 M组,轻度萎缩; N组,无萎缩。与M和N组的患者相比,S组的患者在诊断时具有显着的临床GVHD(P≥0.03)。在S组中,四分之三与M和N组的13名患者中的五名相比,需要添加二线药物(P <= 0.02)。这项研究表明,回肠末端严重萎缩可预示严重的临床GVHD,可能对类固醇激素治疗无效。因此,回肠末端萎缩的严重程度可作为预测临床严重GVHD的工具。试用注册号UMIN 000022805,注册日期为2016年7月1日。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号